Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

June 2014 - FRMC

Specialty Pharmacies Helping to Evaluate Data and Use Technology to Reduce Costs and Improve Quality
06/19/2014
Tampa—Within the next 5 years, specialty pharmaceuticals are expected to account for more than half of the overall drug spending in the United States. By 2016, 8 of the top 10 branded drugs will be specialty medications, while 53 specialty...
Tampa—Within the next 5 years, specialty pharmaceuticals are expected to account for more than half of the overall drug spending in the United States. By 2016, 8 of the top 10 branded drugs will be specialty medications, while 53 specialty...
Tampa—Within the next 5 years,...
06/19/2014
First Report Managed Care
Difficulties in Managing Hepatitis C
06/19/2014
The FDA approved oral medications—sofosbuvir and simeprevir—to treat hepatitis C.
The FDA approved oral medications—sofosbuvir and simeprevir—to treat hepatitis C.
The FDA approved oral...
06/19/2014
First Report Managed Care
Injectable Antipsychotics for Medicaid Patients with Schizophrenia
06/19/2014
Tampa—Approximately 74% of patients with schizophrenia are nonadherent to oral antipsychotic medications. Even short treatment gaps with oral antipsychotics are associated with increased relapse risk, and 80% of patients with schizophrenia...
Tampa—Approximately 74% of patients with schizophrenia are nonadherent to oral antipsychotic medications. Even short treatment gaps with oral antipsychotics are associated with increased relapse risk, and 80% of patients with schizophrenia...
Tampa—Approximately 74% of...
06/19/2014
First Report Managed Care
Treatment Options for COPD
06/19/2014
Orlando—In the United States, half of the 24 million people with chronic obstructive pulmonary disease (COPD) are undiagnosed. Still, a person dies from COPD every 4 minutes. The disease is the fourth leading cause of death and will be the...
Orlando—In the United States, half of the 24 million people with chronic obstructive pulmonary disease (COPD) are undiagnosed. Still, a person dies from COPD every 4 minutes. The disease is the fourth leading cause of death and will be the...
Orlando—In the United States,...
06/19/2014
First Report Managed Care
FDA-Approved Drugs and Lifestyle Changes for Obesity
06/19/2014
According to the Centers for Disease Control and Prevention, 34.9% of adults in the United States are obese, while the estimated obesity-related costs are $147 billion per year.
According to the Centers for Disease Control and Prevention, 34.9% of adults in the United States are obese, while the estimated obesity-related costs are $147 billion per year.
According to the Centers for...
06/19/2014
First Report Managed Care
National Pain Strategy for Opioids and Other Medications
06/19/2014
Orlando—A 2011 report from the Institute of Medicine (IOM) found that chronic pain affects 116 million people in the United States, more than the total affected by heart disease, cancer, and diabetes combined. The disease also costs the...
Orlando—A 2011 report from the Institute of Medicine (IOM) found that chronic pain affects 116 million people in the United States, more than the total affected by heart disease, cancer, and diabetes combined. The disease also costs the...
Orlando—A 2011 report from the...
06/19/2014
First Report Managed Care
Liver Impairment and Renal Impairment Related to COPD
06/19/2014
San Diego—Patients with chronic obstructive pulmonary disease (COPD) who also had mild and moderate liver impairment or severe renal impairment tolerated a single orally-inhaled dose of olodaterol, according to 2 single-center, open-label...
San Diego—Patients with chronic obstructive pulmonary disease (COPD) who also had mild and moderate liver impairment or severe renal impairment tolerated a single orally-inhaled dose of olodaterol, according to 2 single-center, open-label...
San Diego—Patients with chronic...
06/19/2014
First Report Managed Care
Nintedanib Is Safe and Effective in Treating Idiopathic Pulmonary Fibrosis
06/19/2014
San Diego—Patients with idiopathic pulmonary fibrosis (IPF) who received 150 mg of nintedanib twice daily had a significant reduction in the rate of decline of forced vital capacity (FVC) compared with a placebo group, according to 2 phase 3,...
San Diego—Patients with idiopathic pulmonary fibrosis (IPF) who received 150 mg of nintedanib twice daily had a significant reduction in the rate of decline of forced vital capacity (FVC) compared with a placebo group, according to 2 phase 3,...
San Diego—Patients with...
06/19/2014
First Report Managed Care
Interferon-Free Antiviral Regimen for Hepatitis C Patients without Cirrhosis
06/19/2014
A recent study has shown that an 8-week regimen consisting of the antiviral agents ledipasvir and sofosbuvir was just as effective as a 12-week regimen in previously untreated patients with hepatitis C without cirrhosis [N Engl J Med. DOI:...
A recent study has shown that an 8-week regimen consisting of the antiviral agents ledipasvir and sofosbuvir was just as effective as a 12-week regimen in previously untreated patients with hepatitis C without cirrhosis [N Engl J Med. DOI:...
A recent study has shown that an...
06/19/2014
First Report Managed Care
Combination Interferon-Free Treatment for Previously Treated and Untreated Patients with Hepatitis C and Cirrhosis
06/19/2014
Combination treatment of ritonavir-enhanced ABT-450 with ombitasvir, dasabuvir, and ribavirin was shown to be effective in both previously treated and untreated patients with hepatitis C and compensated cirrhosis, according to a recent study...
Combination treatment of ritonavir-enhanced ABT-450 with ombitasvir, dasabuvir, and ribavirin was shown to be effective in both previously treated and untreated patients with hepatitis C and compensated cirrhosis, according to a recent study...
Combination treatment of...
06/19/2014
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Most Effective Complementary, Alternative Medicine for Psoriasis
11/12/2018
Researchers recently examined complementary and alternative medicine therapies for the treatment of plaque psoriasis and identified the most effective treatments.
Researchers recently examined complementary and alternative medicine therapies for the treatment of plaque psoriasis and identified the most effective treatments.
Researchers recently examined...
11/12/2018
First Report Managed Care
News
House OK’s bill making insurers pay for autism services
07/29/2010
07/29/2010
First Report Managed Care
News Connection
Access to Multiple Health Systems May Put Patients at Risk
12/19/2016
The safety of patients with dementia who received prescriptions through both the Veterans Affairs system and through Medicare Part D was compromised. 
The safety of patients with dementia who received prescriptions through both the Veterans Affairs system and through Medicare Part D was compromised. 
The safety of patients with...
12/19/2016
First Report Managed Care
News
Lower Medicaid Dispensing Fees May Pressure Pharmacies
12/06/2011
12/06/2011
First Report Managed Care
News
Stem Cells Offer Promising Key to New Malaria Drugs - US Research
02/13/2015
Human stem cells engineered to produce renewable sources of mature, liver-like cells can be grown and infected with malaria to test potentially life-saving new drugs.
Human stem cells engineered to produce renewable sources of mature, liver-like cells can be grown and infected with malaria to test potentially life-saving new drugs.
Human stem cells engineered to...
02/13/2015
First Report Managed Care

Video Insights

Videos
Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care
11/13/2024
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...
David Sand, MD, MBA, chief...
11/13/2024
First Report Managed Care
Richard Lipton, MD
Videos
The Evolving Role of CGRP-targeting Therapies in Migraine Prevention
10/31/2024
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.
Richard Lipton, MD, provides...
10/31/2024
First Report Managed Care
Alexander Spira, MD, PhD
Videos
Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer
09/26/2024
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).
Alexander I. Spira, MD, PhD,...
09/26/2024
First Report Managed Care
Videos
Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives
09/25/2024
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.
Learn about research...
09/25/2024
First Report Managed Care
Title Card
Videos
Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable
09/04/2024
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.
View a roundtable discussion on...
09/04/2024
First Report Managed Care
Jordan Bazinsky
Videos
Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions
08/15/2024
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...
Guest expert Jordan Bazinsky...
08/15/2024
First Report Managed Care
Farrukh Awan, MD
Videos
Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia
08/14/2024
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).
Farrukh Awan, MD, highlights...
08/14/2024
Journal of Clinical Pathways
Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

June 2014 Volume 11 Issue 6

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement